Difference between revisions of "Timeline of polycystic ovary syndrome"
From Timelines
(→What the timeline is still missing) |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 15: | Line 15: | ||
{| class="sortable wikitable" | {| class="sortable wikitable" | ||
| − | ! Year !! Month and date !! Event type !! Details | + | ! Year !! Month and date !! Event type !! Details !! |
| + | |- | ||
| + | | 2003 || || || "According to the Rotterdam criteria introduced in 2003, PCOS is defined by at least two of the following: oligo-amenorrhea, clinical or biochemical hyperandrogenism and polycystic ovaries on ultrasound."<ref>{{cite journal |last1=Rasmussen |first1=Christina B. |last2=Lindenberg |first2=Svend |title=The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study |journal=Frontiers in Endocrinology |date=27 August 2014 |volume=5 |doi=10.3389/fendo.2014.00140}}</ref> || | ||
|- | |- | ||
|} | |} | ||
Latest revision as of 10:12, 5 August 2021
This is a timeline of FIXME.
Contents
Sample questions
The following are some interesting questions that can be answered by reading this timeline:
Big picture
| Time period | Development summary | More details |
|---|
Full timeline
| Year | Month and date | Event type | Details | |
|---|---|---|---|---|
| 2003 | "According to the Rotterdam criteria introduced in 2003, PCOS is defined by at least two of the following: oligo-amenorrhea, clinical or biochemical hyperandrogenism and polycystic ovaries on ultrasound."[1] |
Meta information on the timeline
How the timeline was built
The initial version of the timeline was written by FIXME.
Funding information for this timeline is available.
Feedback and comments
Feedback for the timeline can be provided at the following places:
- FIXME
What the timeline is still missing
Timeline update strategy
See also
External links
References
- ↑ Rasmussen, Christina B.; Lindenberg, Svend (27 August 2014). "The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study". Frontiers in Endocrinology. 5. doi:10.3389/fendo.2014.00140.
